Title:
SPECIFIC ANTIGEN BINDING MOLECULE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR
Document Type and Number:
WIPO Patent Application WO/2021/209066
Kind Code:
A1
Abstract:
Provided are a BCMA antibody, a bispecific antigen binding molecule that binds to BCMA and CD3 and a pharmaceutical composition thereof, and a use thereof in preparing an anti-cancer drug or a drug for treating auto-immune diseases.
Inventors:
HUA HAIQING (CN)
BAO RUDI (CN)
BAO RUDI (CN)
Application Number:
PCT/CN2021/088092
Publication Date:
October 21, 2021
Filing Date:
April 19, 2021
Export Citation:
Assignee:
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; A61P37/02; C07K19/00; C12N15/13; C12N15/62; C12N15/63
Domestic Patent References:
| WO2020018820A1 | 2020-01-23 |
Foreign References:
| CN108350076A | 2018-07-31 | |||
| CN105980406A | 2016-09-28 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF:
Previous Patent: USE RESTRICTIONS FOR CROSS-COMPONENT PREDICTION
Next Patent: DECODING CIRCUIT AND CHIP
Next Patent: DECODING CIRCUIT AND CHIP